| 000 | 01693 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516142853.0 | ||
| 264 | 0 | _c20130809 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2013-1115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMassicotte, Marie-Hélène | |
| 245 | 0 | 0 |
_aBody composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cJun 2013 |
||
| 300 |
_a2401-8 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aBody Composition |
| 650 | 0 | 4 | _aCarcinoma, Neuroendocrine |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xmetabolism |
| 650 | 0 | 4 |
_aPiperidines _xadverse effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aQuinazolines _xadverse effects |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xdrug therapy |
| 700 | 1 | _aBorget, Isabelle | |
| 700 | 1 | _aBroutin, Sophie | |
| 700 | 1 | _aBaracos, Vickie E | |
| 700 | 1 | _aLeboulleux, Sophie | |
| 700 | 1 | _aBaudin, Eric | |
| 700 | 1 | _aPaci, Angelo | |
| 700 | 1 | _aDeroussent, Alain | |
| 700 | 1 | _aSchlumberger, Martin | |
| 700 | 1 | _aAntoun, Sami | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 98 _gno. 6 _gp. 2401-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2013-1115 _zAvailable from publisher's website |
| 999 |
_c22628854 _d22628854 |
||